Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2015

Differences in Fecal Metabolite Profiles from Geographically
Distinct Populations of Adolescents
Jessica Moncivaiz
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Molecular Biology Commons

Repository Citation
Moncivaiz, Jessica, "Differences in Fecal Metabolite Profiles from Geographically Distinct Populations of
Adolescents" (2015). Browse all Theses and Dissertations. 1628.
https://corescholar.libraries.wright.edu/etd_all/1628

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

Differences in fecal metabolite profiles from geographically distinct
populations of adolescents

A thesis submitted in partial fulfillment of the requirements
For the degree of Masters of Science

By:

Jessica Danielle Moncivaiz
B.S., Wright State University, 2014

2015
Wright State University

Wright State University
Graduate School
Date: November, 2015

I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY
SUPERVISION BY Jessica Moncivaiz ENTITLED Differences in fecal metabolite
profiles from geographically distinct populations of adolescents BE ACCEPTED IN
PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF
Master of Science
__________________________
Oleg Paliy, Ph.D.
Thesis Director
__________________________
Madhavi Kadakia, Ph.D.
Chair, BMB Department
College of Science and Mathematics
Committee on Final Examination
_______________________
Oleg Paliy, Ph.D.
_____________________
Weiwen Long, Ph.D.
_______________________
Nicholas Reo, Ph.D.
______________________

Robert E. W. Fyffe, Ph.D.
Vice President for Research and
Dean of the Graduate School

Abstract
Moncivaiz, Jessica Danielle. M.S., Biochemistry and Molecular Biology M.S. Program,
Wright State University, 2015. Differences in fecal metabolite profiles from
geographically distinct populations of adolescents.
Microbiota of the gastrointestinal tract have a variety of functions within the
human body. They participate in protection of the host from pathogens, aid in immune
system development and regulation, and carry out a variety of metabolic functions. This
study focuses on the ability of gut microbiota to create metabolites through the
degradation of food products. Using 1H NMR on fecal water extracts, I compared the
metabolite profiles of two geographically distinct cohorts: healthy adolescents from
Egypt (n=28) and healthy adolescents from the United States (n=14). Multivariate
statistical analyses of binned NMR data confirmed that samples separated into groups
corresponding to sample class. Quantification of metabolites revealed several metabolites
that differed between groups. For example, levels of short chain fatty acids were higher in
the Egyptian adolescents and most quantified amino acids were higher in the US
adolescents. Multivariate statistical analyses of the quantified metabolite data showed
separation based on the variability within the samples and placed samples into the correct
class. Therefore, I concluded that fecal metabolite profiles differ between Egyptian and
United States adolescents, and that these differences in metabolite levels may be linked to
dietary differences between these two studied cohorts.
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1. Introduction
Microbes
Microbes are very diverse organisms that cannot be seen by the naked eye but are
abundant in every environment on earth. They have the capability to thrive in air, soil,
rock, and even water [1]. They can be classified into six different groups’: bacteria,
viruses, fungi, protozoa, algae, and archaea [2]. Many communities of microbes are
located in these different environments, ranging from hundreds to even thousands of
species [3]. These communities are important for a variety of ecosystem processes
including energy flow, element cycling, and biomass production. They can also play a
role in energy and nutrient processing [3]. Due to the complex nature of these
communities and their interactions with the host and within themselves, attempts to
analyze them have been challenging.

Identification of microbes
Despite the many challenges of studying microbes, researchers have made
significant progress in understanding them through the advancements in molecular and
high through-put technologies. Classical identification of microbiota located in areas like
the gastrointestinal tract (GIT) have been studied through cultivation on Petri dishes.
However, a lot of bacteria located in the GIT are hard to cultivate due their inability to
survive aerobic conditions [4]. To obtain a broader view of the communities present in
the GIT, molecular techniques have been developed for the sequencing of the small
ribosomal subunit RNA (16S rRNA) gene. These approaches use polymerase chain
reaction (PCR) primers, complementary to flanking conserved regions of the 16S rRNA
1

gene, selecting this gene for amplification and enriching it in a sample. The resulting
amplicons are further scrutinized by certain variable regions to classify sequences into
operational taxonomic units (OTUs) [5]. These OTU profiles allow scientists to
differentiate between samples by analyzing the microbial community composition. These
types of analyses are critical to better understand microbial functions and their
relationships to human health.

Microbes association with human health
Microbiota-human interactions are generally thought to be beneficial to health,
but can be harmful under certain conditions [6]. For example, the skin is normally
inhabited by phyla of bacteria such as Actinobacteria, Bacteroidetes, Firmicutes, or
Proteobacteria. This commensal bacteria of the skin can produce defense molecules or
natural antibiotics to protect form pathogens [7]. However, increased colonization of S.
aureus (a member of the Firmicutes phyla) can cause a chronic, inflammatory infection
called atopic dermatitis (AD) [8]. According to a review by Wade, the human oral cavity
is dominated by genera such as Actinomyces, Streptococcus, Neisseria, and Veillonella
[9]. These commensal microbiota of the oral cavity defend against pathogens by
colonization resistance and can also produce molecules to protect the host from infection.
However, when species of microbiota that produce acid shift the microbiome in the oral
cavity, dental carries (tooth decay) can occur and dissolve the tooth structure [9]. Finally,
another important example of this interaction are the human GIT microbiota and their
ability to interact with metabolites, which can contribute to host health. This relationship
will be explained in much greater detail in the following sections.
2

Human gastrointestinal tract microbiota establishment
The human GIT is made up of epithelial cells, lamina propia, and muscularis
mucosae and is home to around 1014 microbial cells [10]. The GIT microbiota are
established at birth. Prior to birth the infants microbiota are undifferentiated across all
body habits but based on the birthing method (vaginal or caesarian section) and the type
of feeding (breast vs. formula) the developing microbiota can change composition [11].
Vaginally delivered infants’ GIT microbiota are dominated by genera such as
Lactobacillus, Prevotella, and Atopobium, bacteria found in the vaginal canal, whereas
infants born via C-section are dominated by Staphylococci, bacteria found on the skin
[12]. After about a year, the infants microbiota profile starts to become similar to those of
adults, having abundance of the phyla's Bacteroidetes and Firmicutes [13, 14]. These
varying factors can contribute to a difference in microbial composition found within the
GIT.

Human gastrointestinal tract microbiota distribution and differences
Not only do gut microbiota profiles differ by age but they also differ with respect
to the region of the GIT they inhabit. The GIT is a large muscular tube that includes the
mouth, esophagus, stomach, small intestine (duodenum, jejunum, and ileum), and large
intestine (appendix, cecum, colon, and rectum) [15]. The microbiota differ due to
physicochemical conditions such as pH, motility, redox potential, nutrients, and
secretions by the host. As the GIT progresses through the body the microbial cell density
(per gram of intestinal content) increases from 101-104 cells in the stomach and
duodenum, 104-108 cells in the jejunum and ileum, and 1010-1012 cells in the colon [16].
3

Along with the density increase the type of bacteria present in various sections of the GIT
is different. For example, in a study done by Frank et. al., the colon and small intestines
were analyzed and found to have different microbiota compositions. The small intestine
had a higher abundance of Bacillus and a lower abundance of Bacteroidetes and family
Lachnospiraceae [17]. Overall, compared to the large intestine the small intestine
contained less phylogenetic diversity of Bacteroidetes and Firmicutes [17]. Differences
within the sections of the GIT can cause a difference in microbiota composition.

Functions of microbiota of the gastrointestinal tract
The microbiota of the GIT have many critical functions including protection
against pathogens, development of the immune system, and metabolic functions. For
example, commensal bacteria protect the gut environment from pathogenic bacteria
through competitive inhibition [10]. The commensal bacteria also produce toxins and
metabolites that can inhibit or stunt the growth of potential pathogenic bacteria. If this
protective layer of commensal bacteria is disrupted by antibiotics then pathogenic
bacteria such as Clostridium difficile can colonize and flourish. This bacteria can cause
pathophysiological conditions such as Clostridium difficile infection (CDI) which
presents symptoms like diarrhea, nausea, and abdominal cramping for the host [18].
Therefore, the competitive environment against pathogenic bacteria established by the
commensal bacteria is very important for the health of the host.
Another function of the GIT microbiota is its role in the development of the
immune system and response. The gut immune system consist of peyer's patches, lamina
propia lymphocytes, intra-epithelial lymphocytes, and mesenteric lymph nodes that have
4

gut-associated lymphoid tissue (GALT) [10]. IgA, an important immunoglobulin secreted
into the GIT can coat and protect commensal bacteria and also respond to pathogens on
mucosal surfaces. It has been shown that IgA is important for maintaining GIT
microbiota homeostasis and composition [19]. A study by Suzuki et. al., showed that
mice with a deficiency of activation-induced cytidine deaminase (AID) produced more
IgM than IgA. This dysregulated the GIT microbiota community and caused increase
activation of GALT [19]. Dysregulation of the immune system can result in further host
related problems, including a variety of autoimmune diseases.
Microbiota are also important for a variety of metabolic functions due to their
ability to create metabolites and vitamins that can be used by the host through the
degradation of various food products. For example, a review by Tremaroli et. al. showed
GIT microbiota can degrade non-digestible carbohydrates, that cannot be degraded earlier
in the GIT by the host, including cellulose, xylans, resistant starch, and inulin [20]. The
end products of this metabolism creates short chain fatty acids (SCFAs) acetate,
propionate, and butyrate [20]. Peptides and proteins can also be metabolized by GIT
microbiota to produce amino acids, SCFAs, and even some toxic substances such as
ammonia and indols [21]. Gut microbiota can also metabolize dietary products, such as
choline, into methylamines [11]. Understanding the ability of microbiota in the GIT to
regulate metabolic functions can help researchers to better understand their impact on
overall human health.

5

Metabolite functions and importance in human health
Short chain fatty acids
A review by Macfarlane et. al. highlights SCFAs as a major metabolic end
products produced in the human large intestine by bacteria [22]. They are primarily
produced from digestion of polysaccharides, oligosaccharides, and proteins [20].
Enzymes degrade these large macromolecules and allow the microbiota to ferment the
sugars. Fermentation substrates can include starches and plant cell-wall polysaccharides
(celluloses, pectins, and xylans) that are not degraded or absorbed in the small intestine.
The main SCFAs produced by this fermentation are acetate, propionate, and butyrate.
However, other SCFAs such as formate and valerate are formed during catabolism of
branched-chain amino acids [20]. Even lactate, ethanol, and succinate, can to some
extent, be metabolized into SCFAs in the GIT [22].
SCFAs have many effects in the host and have been implicated in several health
benefits. SCFAs can be used by the host as energy substrates for colonic epithelium,
peripheral tissues inflammation modulators, vasodilators, and promote wound healing
[20]. More specifically, butyrate enhances fatty acid oxidation and thermogenesis in
muscle and liver tissue [23]. Propionate and butyrate are known to activate intestinal
gluconeogenesis which promotes metabolic benefits on weight and glucose control [23].
Acetate can reduce appetite by changing expression of neuropeptides through the
activation of the tricarboxylic acid cycle (TCA) [23].
SCFAs have also been shown to have anti-inflammatory and anti-cancer
properties by several studies. The anti-inflammatory property of SCFAs could be used as
a potential treatment of gastrointestinal inflammatory diseases such as Crohn’s disease
6

and inflammatory bowel disease (IBD) [24]. In a study done by Tedelind et. al., they
found that SCFAs inhibit lipopolysaccharide-stimulated release of tumor necrosis factor
alpha (TNF ), a cytokine involved in systemic inflammation in human neutrophils. They
also showed that SCFAs inhibited the NF-kB pathway, an inflammatory pathway
activated by cytokines [24]. Other studies have shown SCFAs role against colon cancer.
For example, studies have shown that SCFAs act as ligands for G-protein coupled
receptors like GPR43, which are found in normal human colon tissue. In a study done by
Tang et. al., they showed that GPR43 expression was lower in human colon cancer cell
lines. However, when they restored GPR43 in colon cancer cells along with the presence
of propionate, it retarded growth and increased apoptosis [25]. SCFAs have the capability
to promote positive health effects and could be used as a potential treatment for
inflammatory GIT diseases.
Amino acids
Proteins can also be degraded in the large intestine by certain proteolytic
microbiota species into amino acids. Proteins that aren’t broken down earlier in digestion
reach the colon, where bacterial proteases and left over pancreatic endopeptidases break
them down into amino acids. Around 12 grams of proteinaceous material enters the colon
a day, 49-51% coming from protein and 20-30% coming from peptides [26]. Protein can
be further broken down by hydrolysis creating amino acids groups such as aromatic,
sulfur, and other amino acids. Then amino acids can be broken down into other
compounds. Aromatic amino acids like tryptophan go through an elimination reaction
and become phenolic and indolic compounds, while other amino acids can go through
deamination, decarboxylation, or fermentation which create ammonia, amines, or other
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organic acids [27]. The protein that makes it to the colon is believed to come from around
50% of dietary sources and levels can vary based on certain foods [26].
High protein intake from food products such as meat has been linked by several
studies to certain diseases. When meat is cooked it creates N-nitroso compounds (NOCs),
heterocyclic amines (HCAs), and polycyclic aromatic hydrocarbons (PAHs); all these
compounds are cacogenic and can cause DNA damage [28]. Also wide variety of cancers
(colorectal cancer, lung cancer, liver) have been associated with red meat and processed
meat intake [29]. In a study done by Smolinska et. al., researchers performed metaanalysis on seven cohort studies that took place from 1994-2007 to determine risk of
colon cancer. They found that red meat intake of over 50 g/day can cause colonic
carcinogenesis and red meat intake more than once per day can cause colonic and rectal
cancers [28]. Another study done by Pan et. al., linked red meat to increased risk of type
2 diabetes (T2D). This study followed three different cohorts of over 4 million US
citizens’, male and female. The researchers accessed red meat consumption (processed
and unprocessed) and T2D by questionnaires. Using statistics and meta-analysis they
found a positive correlation between T2D and red meat consumption [30]. Amino acids
especially from intake of meat products can cause a variety of disease that are harmful to
the host.
Bile acids
Bile acids are important regulators for cholesterol balance and for
digestion/absorption of lipids within the small intestine. They act as emulsifiers of lipids
and fat-soluble vitamins and are the primary mediators of cholesterol catabolism. When
bile acid synthesis occurs in the liver, primary bile acids such as cholic acid and
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chenodeoxycholic acid (CDCA) are formed. Before bile acids are stored in the
gallbladder as micelles with phospholipids and cholesterol, primary bile acids are
conjugated with taurine or glycine to enhance hydrophilicity. After a meal is ingested the
gallbladder releases the bile acids into the intestinal lumen to help with digestion of food
products. When bile acids reach the GIT around 5-10% are deconjugated by the
microbiota to create secondary bile acids such as deoxycholic and litocholic acids (DCA,
LCA), and can then be reabsorbed or eliminated in the feces [31].
Bile acids have been implicated as possible causative agents for various cancers
of the GIT and have been shown to be involved in inflammatory pathways in GIT cells.
Individuals on high fat diets have been shown to have high amounts of bile acids and this
can cause cells to be exposed to reactive oxygen species (ROS) and reactive nitrogen
species (RNS). These agents can cause DNA damage, increased mutations, and apoptosis
which could lead to various GIT cancers [32]. In a study by Bernstein et. al., mice were
fed a diet that had high physiological levels of DCA, a common bile acid found in feces,
to see if it had the potential to induce colon cancer. DCA was given to the mice for 8-10
months, DCA induced colonic tumors in 17 of the 18 wild type-mice [33]. Another study
by Schlottman et. al., showed that bile acids had the ability to cause apoptosis in human
colon cancer cell lines. Looking at HT-29, Caco-2, and SW480 colon carcinoma cell lines
they found that varying concentrations of DCA caused apoptosis. They also showed
caspase cleavage and activation, molecules responsible for biochemical change in cells
undergoing apoptosis, occurred after the addition of deoxycholate [34]. Another study by
Morbraten et. al., showed that triggering TGR5, a bile acid cell surface receptor,
enhances lipopolysaccharide inflammatory response in monocytic cell lines. Bile acids
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DCA and CDCA, activated MAP kinases ERK 1/2, p38, and JNK, major pathway
activated by stress and inflammation. They also activated NF-kB signaling (inflammation
pathway) and the release of inflammatory cytokines. The researchers believe that since
LPS may contribute to insulin resistance, that TGR5 activation may also play a role [35].
This gives evidence that bile acids can have damaging effects on cells and their potential
to lead to a variety of cancers.
Taurine
Taurine is an important dietary nutrient often referred to as a semi-essential amino
acid (even though it lacks a carboxyl group) because mammals have limited ability to
synthesize taurine and have to get it through their diet [36]. Taurine is acquired through
the synthesis of cysteine and methionine, through absorption of food, excretion of
taurocholate (bile salt), or unconjugated taurine in the urine. The taurine source in the
intestines is mainly from the deconjugation of bile acids (taurocholic acid,
taurochenodeoxycholic acid) by GIT microbiota through bile salt hydrolases [11].
Taurine has been shown to be important in many biological functions of the body.
Taurine has a zwitterionic capability making it highly soluble in water and low
lipophilicity. These properties contribute to taurine’s membrane impermeability, high
dipole nature, interactions with cations, membrane modulatory, and conjugation with bile
acids. It has also been shown in studies to play a role in post-translational modification of
mitochondrial tRNAs. High taurine levels can be found in foods such as beef, pork, fish,
and shellfish [36]. It has also been shown to be high in energy drinks [36].
Taurine is an important nutrient in the body for normal function but when
combined or taken in high amounts can cause adverse health problems. When the taurine
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transporter (TauT) is knocked out in mice many health problems can occur such as
reduced exercise capability, loss of retinal photoreceptor function, degeneration of the
inner ear, cardiomyopathy, reduced T-cell memory generation, and hepatitis/liver
fibrosis. Taurine can regulate cell volume, contribute to pool of organic osmolytes,
stabilize membranes, serve as an antioxidant, and has anti-inflammatory/anti-apoptotic
effects [36]. Taurine has also been shown to have adverse effects especially when
combined with caffeine or in the high amounts present in energy drinks. It has been
reported to increase systolic blood pressure and increase heart rate. Long term taurine
consumption has also been implicated in human and animal studies to cause
hypoglycemia [37].
Choline
Choline is a water soluble nutrient that is utilized in many pathways in the body.
Choline can be obtained in the diet through foods such as eggs, liver, meats, and wheat
germ or produced endogenously [38]. Choline is a key component to make membrane
phospholipids, used as a methyl donor in the betaine production, and it is acetylated to
make acetylcholine, an important neurotransmitter [39]. Choline can also influence other
processes such as lipid metabolism, activation of nuclear receptors, circulation of bile and
cholesterol, plasma membrane fluidity, and the bioenergetics of mitochondria. Dietary
choline has been shown to be excreted in urine as N, N-dimethylglycine and leads to the
production of creatine and creatinine. It can also be converted into methylamines by GIT
microbiota after high fat consumption [40].
Choline has been associated with several health issues including liver and
cardiovascular disease. In a study done by Sha et. al., they found that metabolomics
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profiling of choline and related metabolites were able to predict which participants fed a
certain diet (high or low choline) would develop liver dysfunction. They found that of the
53 patients, 9 developed liver dysfunction or muscle dysfunction when given a diet low
in choline and 23 participants developed hepatic steatosis (fatty liver) [39]. Another study
by Dumas et. al., mice fed a high fat diet had reduced bioavailability of choline. This is
because the GIT microbiota converted the choline into methylamines (trimethylamine,
dimethylamine, trimethylamine-N-oxide) which mimicked effects of a choline-deficient
diet and caused non-alcoholic fatty liver disease (NAFLD) [40]. Choline is needed by our
bodies for a variety of functions and can protect from disease like NAFLD.

Nuclear magnetic resonance use in metabolomics
Nuclear magnetic resonance (NMR) spectroscopy is the measurement of
absorption or emission of frequency energy by nuclei in a magnetic field. The output of
this process is specific resonances (peaks) that correspond to different compounds. NMR
spectroscopy is a dynamic tool that is nondestructive, capable of identifying structural
and conformational analyses of complex molecules, and can quantitate complex mixtures
of molecules [41]. NMR spectroscopy has recently been shown as a useful technique in
metabolite analyses, especially in the metabolic profiling of biofluids (such as fecal
material). The reasons it is so effective is because it requires little to no sample
preparation and is nondestructive/noninvasive to the sample [42]. These qualities make
NMR a great technique to use for metabolite profiling.
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Metabolite profiling of the human gut
In order to gain a better understanding of the impact of nutrition on the human gut
microbiome Jacobs et. al., introduced the idea of 1H NMR metabolite profiling of feces.
In this study the researchers’ first generated metabolite profiles by water and methanol
extraction of lyophilized feces and they obtained a variety of metabolites e.g. amino
acids, SCFAs, organic acids (e.g. succinate, pyruvate), uracil, ethanol, cholate, and
glucose [43]. Then to validate this approach they did another study where they placed
human subjects on either a placebo, grape juice extract, or grape juice wine extract for 4
weeks. The goal of the researchers was to see if metabolite profiles of feces changed
based on dietary changes. They found that the grape juice extract did not change the
metabolite profiles of individuals compared to the placebo. However, the individuals
placed on the grape juice wine extract did cause a reduction in isobutyrate [43]. Another
study similar to Jacobs et. al., was performed by Ndagijimana et. al., looking at effects of
synbiotic food on the metabolite profiles of the gut using 1H NMR. They feed 16 healthy
subjects synbiotic food for a month and looked at the difference prior to consumption and
after consumption. They were able to detect 150 metabolites and the biggest changes
between start and end of diet was that SCFAs increased and amino acids decreased [44].
These studies show the efficiency of 1H NMR metabolic profiling on fecal material to
determine differences based on dietary changes.
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Metabolite differences related to geography and regional diet
Differences in metabolites and microbiota can also be determined by geographical
location and what foods are available in those different locations. A study done by De
Filippo et. al., compared the fecal material between two groups of adolescents: an African
group called the Mossi from Burkina Faso (BF) and European adolescents from Florence,
Italy (EU). The BF diet is low in fat and animal protein but rich in starch, fiber, and plant
polysaccharides. The EU diet is rich in animal protein, sugar, starch, and fat but low in
fiber. The researchers found that the groups had enrichment of certain GIT bacteria that
are known to degrade polysaccharides and BF adolescents had significantly more SCFAs
compared to the EU. They believe these differences are due to their differing diet [45].
Another study, done by Schnorr et. al., compared metabolites and microbiota
from the Hadza hunter gatherers from Tanzania and adults from Bologna, Italy. The
Hadza diet consists of wild foods such as meat, honey, baobab, berries, and tubers. As
where the Italian cohort’s diet followed more of a Mediterranean diet consisting of plant
foods, fruit, pasta, bread, and olive oil. The Italian cohort dietary source of carbohydrates
mostly came from digestible starch and sugar, with little indigestible fiber. The study
showed the Hadza group has higher microbial richness and diversity than the Italian
group. The Hadza group also had a higher enrichment of bacteria involved with the
digestion of fibrous plant foods. The researchers also found that Italian samples had
higher levels of butyrate and the Hazda had higher levels of propionate [46].
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Differences between U.S. and Egyptian diets
In this study, we profiled metabolite differences of Egyptian and US teenagers.
Diets of these two populations are thought to be different which can impact GIT
microbiota. Figure 1.1 and 1.2 give an overview of the main diet differences between
Egyptians and United States adolescents.

Bread
Cereals
Legumes
Dark leafy green
vegetables

Some dairy
products
Meat
consumption
Saturated fats

Low Intake

High Intake

Figure 1.1: Egyptian diet

Figure 1.1 shows foods of high and low intake in the Egyptian diet

Refined grains
Added fats
Meat/protein

Fruit
Vegetables
Dietary fiber

Low Intake

High Intake

Figure 1.2: United States diet

Figure 1.2 shows foods of high and low intake in the United States diet
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According to a review published by H. Hassan-Wassef explaining the basic
features of the Egyptian diet; bread made from wheat flour is one of the main food staples
in the Egyptian diet and eaten with almost every meal. Cereals and legumes are also very
popular in the diet and are the main source of calories and protein. Egyptians regularly
intake fresh dark green leafy vegetables such as cabbage, spinach, and grape leaves. Also
small amounts of cheese and dairy products are consumed regularly. Meat consumption
is lower because it tends to be regarded as a luxury item and due to religious and cultural
reasons cannot be consumed at certain times. Egyptian diet is traditionally low in
saturated fats and oil is more commonly used than butter [47].
The United States diet patterns vary from that of the Egyptians. According to a
review published by D. Grotto on the US diet, there are foods eaten in excess and foods
under-consumed by the US population. These numbers are calculated based on a 2,000
kilo-calorie per day intake recommended by the Dietary Guidelines for Americans
(DGAs) created by the United States Department of Agriculture (USDA) and U.S.
Department of Health and Human Services. It is recommended that Americans eat
6ounce-equivalents (oz-eq) of grain per day, however it has been shown that they eat 8.1
oz-eq per day. Most of these grains are refined (7.2 oz-eq) and not the recommended
whole grains. It is suggested to ingest 4.5 cups of fruits and vegetables (leafy green,
legumes, orange, and starchy vegetables) per day; 2 cup from fruit and 2.5 from
vegetables. The US population is currently consuming 0.9 cups of fresh and processed
fruit and 1.7 cups of fresh and processed vegetables. Dietary fiber recommended intake is
around 28g per day but the US population only consume 15.2 g per day. Meat and beans
(not including legumes), however are over consumed. It is recommended 5.5 oz-eq per
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day, and actual intake is 6.5 oz-eq per day. The recommended total intake of fat to be
between 25%- 35% of total calories a day. American’s have been shown to consume
around 71.6g of added fats and oils per person per day [48].

Thesis overview
The work in this thesis involved the comparison of metabolite profiles of two
geographically distinct cohorts, healthy Egyptian adolescents (n=28) and healthy United
States adolescents (n=14). Fecal water extracts to obtain water soluble metabolites were
made from collected fecal samples and 1H Nuclear Magnetic Resonance (1H NMR) on
the extracts was performed by Dr. Nicholas Reo’s Laboratory at Wright State University,
Dayton, Ohio. The binned NMR data obtained from the 1H NMR were ran through
multivariate statistical tools to determine differences between samples. Next, applying
spectrum deconvolution, a method for differentiating peaks of interest, quantification of
32 metabolites was done. Metabolite peak validation procedure (spike-in) was used to
confirm peak assignments for metabolites with suspect peaks. Finally, after confirmation
and quantification of all the metabolites, the metabolite data was transformed to centerlog ratio and multivariate statistical tools were ran.
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2. Materials and Methods
Sample Collection
Samples were collected from two different groups; healthy adolescents from
Egypt (egkHLT) and healthy adolescents from the United States (uskHLT). egkHLT
samples were collected by Dr. Laila Hussein from The National Research Center located
in Giza Governorate, Egypt and uskHLT samples were collected by Dr. Oleg Paliy’s
laboratory and Dr. Sonia Michail’s at Wright State University and Dayton Children’s
Hospital located in Dayton, Ohio. Volunteers defecated into sterile collection containers
that were then immediately stored at -80℃. The cohort consisted of 28 male samples
from egkHLT and 14 male samples from uskHLT. Table 2.1 and 2.2 details sample
name, age, gender, and BMI
2.1: Volunteer information for uskHLT samples
Sample (uskHLT) Age
BMI
uskHLT05
12
19.9
uskHLT08
15
22.1
uskHLT13
10
22.6
uskHLT14
11
23.8
uskHLT17
10
17.2
uskHLT20
12
21.5
uskHLT22
18
25.6
uskHLT24
16
16.7
uskHLT26
10
17.3
uskHLT27
9
18.4
uskHLT29
12
26.5
uskHLT30
14
18.4
uskHLT31
15
25.8
uskHLT32
16
20.4
Average
13.0 ± 0.7 21.2 ± 0.9
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Table. 2.2: Volunteer information for egkHLT samples
Sample (egkHLT) Age
BMI
egkHLT01
14
19.5
egkHLT02
15
23.7
egkHLT03
14
22.0
egkHLT04
14
17.6
egkHLT05
15
21.8
egkHLT06
13
17.3
egkHLT07
14
17.4
egkHLT08
13
17.3
egkHLT10
14
16.9
egkHLT11
13
15.5
egkHLT12
13
17.3
egkHLT14
14
18.9
egkHLT15
14
17.3
egkHLT16
14
16.9
egkHLT17
14
18.2
egkHLT19
13
19.6
egkHLT20
15
17.5
egkHLT22
14
19.2
egkHLT23
15
24.5
egkHLT24
14
17.9
egkHLT25
13
17.1
egkHLT26
14
15.6
egkHLT27
14
17.7
egkHLT28
14
18.0
egkHLT29
14
19.9
egkHLT30
14
25.5
egkHLT31
14
20.3
egkHLT32
14
19.2
Average
14.0 ± 0.1 18.9 ± 0.5

Fecal water extraction
Fecal water extractions were performed to obtain water soluble metabolites for 1H
NMR. The phosphate buffer solution used in the protocol contained 2.0 mg KCl, 11.5 mg
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Na2HPO4-7H2O, 2.0 mg KH2PO4, and 10 ml H2O. After the phosphate buffer was made
the fecal water extraction protocol was performed. The protocol is the following:
a) 250 mg of fecal sample was weighed and placed in 2 ml eppendorf tubes
b) 1.25 ml of 1x phosphate buffer was added to the tube and vortexed at maximum
speed for 5 minutes to homogenize samples
c) The homogenized samples were centrifuged at maximum speed in the
chromatography fridge for 5 minutes at 1600g in 4 ℃
d) Supernatant was collected and filtered through Whatman GDX filter using a
syringe and eluted into a 1.5 eppendorf tube
e) Eluate was centrifuged in the chromatography fridge for 15 minutes at 1600g in 4
℃
f) The supernatant was aliquoted into two clean 1.5 ml eppendorf tubes and placed
in the -70℃ freezer

Proton nuclear magnetic resonance 1H NMR analysis of fecal water
extracts
Proton NMR was done to determine metabolite composition within the collected
fecal samples. This was carried out by Dr. Nicholas Reo’s Laboratory at Wright State
University in Dayton, Ohio. A 550-600 μl aliquot of the fecal extract sample was
transferred into a 5 mm NMR tube with 150 μl of 9 mM trimethylsilypropionic-2.2, 3, 3d4acid (TSP) in D2O. 1H NMR spectra were acquired at 25 ℃ using a Varian INOVA
operation at 600 MHz (14.1 Tesla). The TSP was a chemical shift standard used for
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reference and quantification. The spectra were pre-processed using a standard protocol
employed in Dr. Reo’s laboratory [49].
To use this data for multivariate analyses, the spectral data are binned. Binning is
the process of dividing the spectrum into several hundred non-overlapping regions of the
same size. Binning attempts to lessen the effects of variation in peaks position that can be
caused by pH, ionic strength, composition, and reduce the dimensionality for multivariate
statistical analyses [50]. The method for binning on the data set is a dynamic
programming-based adaptive binning technique developed by Anderson et al 2011 and
was carried out by Dr. Reo’s laboratory [50].

NMR spectrum deconvolution
Deconvolution algorithm was employed in MATLAB R2014a (Mathworks Inc) to
determine peak areas of the 32 selected metabolites [50]. The purpose of deconvolution is
to identify known peaks from other peaks that can overlap in the same region. The
deconvolution software works by fitting a defined spectral region using a combination of
baseline shapes (spline, v-shaped, linear, or constant) and a Gauss-Lorentz peak-fitting
function. Figure 2.1 shows an example (uracil, ppm ~ 5.80) of the deconvolution process
before the line fitting and peak validation and Figure 2.2 is after the line fitting and peak
validation by the user. After deconvolution is done a better estimate of the peak area can
be determined. Areas for peaks of interest are outputted in text files.
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Figure 2.1: Before deconvolution of uracil

Figure 2.1 shows the spectrum of uracil before using the deconvolution algorithm to correct peak
fitting. The two black arrows point to unfitted areas of the spectra.

Figure 2.2: After deconvolution of uracil

Figure 2.2 shows the spectrum of uracil after the deconvolution algorithm to correct peak fitting.
The two black arrows point the areas that were fitted by the algorithm.
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Metabolite quantification
After deconvolution all the metabolite peak intensities were corrected for
equivalent number of protons then normalized relative to TSP signal intensity through an
excel template provided by Dr. Reo's laboratory. The extracts were prepared from
identical stool weight so the relative comparisons between the samples were fully valid.
Peak assignments are based on literature and databases (such as the Human Metabolome
Database) [51].

Validation of metabolite peaks
Due to crowding of metabolite peak signals within some regions of the spectra a
peak validation was done. Using sample uskHLT, four fecal water extracts following the
same protocol were made. Next, nine 100 mM metabolite solutions at volume of 500 l
were prepared, Table 2.3 shows the nine metabolites molecular weights and mass in the
100 mM solution in milligrams. The final concentration was approximately 1.5 mM.
Table 2.3: Molecular weights and mass of 100 mM solution in mg of each metabolite
Metabolite Molecular Weight g/mol Mass to obtain 100 mM Solutions (Volume)
Isoleucine
131.2
6.6
Leucine
131.2
6.6
Tryptophan
204.2
10.2
Glucose
180.2
9.0
Methylamine
31.1
1.6
Galactose
180.2
9.0
Sucrose
342.3
17.1
Uracil
112.1
5.6
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The solutions were made with phosphate buffer and H2O. Uracil and tryptophan solutions
were made with H2O and the other metabolite solution were made in phosphate buffer. 4
l of NaOH was added to the tryptophan solution because tryptophan is more soluble in
alkali hydroxides [52]. Then the fecal water extracts and metabolite solutions were given
to Dr. Reo's Laboratory for 1H NMR analysis. Several metabolites were ran in each
extract if their peaks did not overlap, Table 2.4 shows which metabolites were ran in the
same extract.
Table 2.4: Fecal water extract and contents
Extract
1
2
3
4

Metabolites
Leucine, Isoleucine, Methylamine, Tryptophan
Glucose
Sucrose
Galactose, Uracil

Statistical data analyses
Analyses of the compositional 1H NMR binned and metabolite data was through
multivariate analyses. Prior to multivariate analyses several processing steps on the
binned and metabolite quantification data had to be done. First, sample-to-sample withingroup variance was reduced by normalization of binned data where egkHLT and uskHLT
were auto-scaled to both group means [54]. Then center log ratio transformation (clr)
using a custom script developed in our laboratory was performed on the metabolite data
set. Since the data is compositional and is based on a relative scale, this transformation
can remove the effect of constant-sum constrain on the co-varying variables [55]. The
multivariate statistic tests used on this data set were principle component analysis (PCA),
orthogonal projections to latent structures discriminate analysis (OPLS-DA), and
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Random Forest (RF). PCA and OPLS-DA were ran in MATLAB R2014a (Mathworks
Inc.) using custom scripts (Shankar et al 2013), and RF was ran in R x64 3.2.2 [49].
PCA reduces dimensionality in the data set while retaining most of the variation
by creating principle components. The principle components represent the variability
within the data set and are re-ranked according to the amount of variation they represent,
therefore PC1 would have the most variation, PC2 the second most and so on. This
technique is unsupervised meaning that the tool is not told which samples belong to
which groups [56]. PCA was developed in 1901 by Karl Pearson [57].
OPLS-DA finds linear combinations of variables that separate groups. It is
another technique that combines dimensionality reduction with a form of classification
called discriminant analysis. It takes the variability of X that corresponds to Y and puts it
in the T axis and takes the rest of the variability and puts it in the T orthogonal axis. The
X data is the bins/metabolites and Y data is the class information. OPLS-DA is a
supervised model meaning that it told which samples belong to which group. Q2 values
are used to assess the predictive ability of the metric. As Q2 approaches 1 it means that
the model exhibits predictive capability, however if it less than zero it means it has no
predictive power [56]. OPLS-DA was developed by Trygg and Wold, 2002 [58].
Random forest is a method of classification that uses a collection of classification
trees to provide variable importance. It works by using data that relies on random
sampling with replacement (bootstrap) method and random variable selection to build the
trees. RF creates a collection of trees that have low bias and low variance. Then RF then
determines importance scores based on their mean gini scores. Random forest was
developed by Leo Breiman in 2001 [59].
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To evaluate statistical significance of metabolite levels, a Mann-Whitney U-Test
was ran in SPSS (SPSS Inc.).
Correlations analysis was done to find the relationships among metabolites. To do
this, SparCC, method and software established by Freidman and Alm was used [60].
First, correlations were found using the script in Python following these parameters –i 20
inference iterations to average over, -x 10 number of exclusion iterations to remove
strongly correlated pairs, and -t 0.1 correlation strength exclusion threshold. Second, to
calculate pseudo p-values first the bootstrap procedure using the MakeBootstraps script
was done generating 100 shuffled data sets. Next, SparCC was ran again (using the same
parameters) on all 100 of these shuffled data sets to give two sided p-values.

26

3. Results
Ordination analyses of binned data
Principle component analysis
Figure 3.1 shows PCA carried out in MATLAB R2014a demonstrates that the
samples could form two distinct clusters based on overall variability. A few samples did
overlap into opposite clusters meaning that their variability identified more with their
opposite classification. These samples were found to be uskHLT 29 being more related to
egkHLT samples and egkHLT 14 being more related to uskHLT samples. The model's pvalue (p < 0.001) is statistically significant
Figure 3.1 PCA plot of binned data

p<0.001

Figure 3.1 is the plot of principle components analysis of egkHLT
(red) and uskHLT (green) samples. This data is based on the
binned NMR data provided by Dr. Reo’s laboratory.
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Orthogonal projection to latent structure discriminant analysis
Figure 3.2 demonstrates that OPLS-DA had large group separation of T and little
separation of T orthogonal. The model also demonstrates that the binned NMR data is
separated into two groups and samples were placed in the correct groups. The models pvalue (p < 0.001) statistically significant. Q2 value was 0.81 meaning the model had
strong predictive ability.
Figure 3.2: OPLS-DA plot of binned data

p<0.001

Figure 3.2 is the plot of orthogonal projection to latent structure
discriminate analysis of egkHLT (red) and uskHLT (green)
samples. This data is based on the binned NMR data provided by
Dr. Reo’s laboratory.
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Metabolite measurements
Using 1H NMR analysis, 32 metabolites were identified and the deconvolution
algorithm was used to isolate individual metabolite peaks and allow robust quantification.
These values calculated are arbitrary units respective to TSP, an internal chemical shift
standard used in NMR. Tables 3.1-3.3 are all the metabolites identified in the egkHLT
and uskHLT spectra with their chemical shift values in ppm. Figure 3.3 shows the
egkHLT and uskHLT spectra with the peaks identified based on ppm.

Table 3.1: Quantified SCFAs with chemical shifts in ppm
Short Chain Fatty Acids
Acetate
Butyrate
Formate
Propionate
Valerate

Chemical Shift 1H ppm
1.92 (s)
1.56 (tq)
8.46 (s)
1.06 (t)
0.86 (t)

Table 3.1 shows the SCFAs identified and their peak
locations along with peak type, (s) singlet, (d) doublet,
(t) triplet, (dd) doublet of doublets, and (tq) triplet of
quartets.
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Table 3.2: Quantified amino acids with chemical shifts in ppm
Amino Acids
Alanine
Aspartic Acid
Glycine
Isoleucine
Leucine
Lysine
Tryptophan
Tyrosine
Valine

Chemical Shift 1H ppm
1.48 (d)
2.82 (dd)
3.56 (s)
1.01 (d)
0.96 (t)
3.03 (t)
7.54 (d)
6.90 (m)
3.61 (d)

Table 3.2 shows amino acids identified and their peak
locations along with peak type, (s) singlet, (d) doublet,
(t) triplet, and (dd) doublet of doublets

Table 3.3: Quantified metabolites with chemical shifts in ppm
Other Metabolites
1-Methylhistamine
Cholate Bile Acids
Choline
Cytosine
Ethanol
Fumarate
Galactose
Glucose
Hypoxanthine
Lactate
Malate
Methylamine
Pyruvate
Succinate
Sucrose
Taurine
Trimethylamine
Uracil

Chemical Shift 1H ppm
3.25 (t)
0.73 (m)
3.20 (s)
7.52 (d)
1.19 (t)
6.52 (s)
5.27 (d)
5.24 (d)
8.22 (s)
1.33 (d)
4.30 (dd)
2.61 (s)
2.47 (s)
2.41 (s)
4.22 (d)
3.45 (t)
2.90 (s)
5.80 (d)

Table 3.3 shows the other metabolites identified and their
peak locations along with peak type, (s) singlet, (d) doublet,
(t) triplet, and (dd) doublet of doublets.
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Figure 3.3:1H NMR spectra of egkHLT and uskHLT

Figure 3.3 shows the spectra acquired by the 1H NMR of egkHLT (red) and uskHLT (green) samples along with the
identification of the 32 metabolites peaks
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Short chain fatty acids
Table 3.4 shows the quantified (arbitrary units respective to TSP) SCFAs values.
Overall, the SCFAs are higher in egkHLT compared to uskHLT. Acetate, butyrate, and
propionate are all higher in egkHLT. However, formate and valerate are higher in
uskHLT. Mann-Whitney U-Test indicated that differences in acetate, propionate, and
SCFAs total were statistically significant (p≤0.05).
Table 3.4: Short chain fatty acids quantification results
Metabolite egkHLT ±SE uskHLT ±SE Mann-Whitney U Test
Acetate
42.12 0.72
38.36 1.49
0.040
Butyrate
16.04 0.65
15.15 1.02
0.471
Formate
0.55 0.03
0.60 0.06
0.594
Propionate
23.25 0.56
19.66 1.27
0.008
Valerate
1.17 0.13
1.39 0.22
0.455
Total
83.29 1.04
75.10 2.38
0.001
Table 3.4 shows SCFAs quantification results in fractional values of
egkHLT and usKHLT, standard error values, and results of Mann-Whitney
U test (p-values, bolded numbers are statistically significant).

Amino acids
Table 3.5 shows the quantified (arbitrary units respective to TSP) amino acid
values. Amino acid totals are higher in uskHLT compared to egkHLT. Alanine, aspartic
acid, isoleucine, leucine, lysine, tyrosine, and valine are all higher in uskHLT. Glycine
and tryptophan are higher in egkHLT. Mann-Whitney U-Test indicated that differences in
aspartic acid, isoleucine, leucine, lysine, tryptophan, tyrosine, valine and the amino acid
total were statistically significant (p≤0.05).
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Table 3.5: Amino acids quantification results
Metabolite
Alanine
Aspartic Acid
Glycine
Isoleucine
Leucine
Lysine
Tryptophan
Tyrosine
Valine
Total

egkHLT
1.97
0.35
0.67
0.50
0.66
2.01
0.78
0.28
0.14
7.57

±SE
0.19
0.02
0.08
0.05
0.07
0.27
0.08
0.03
0.01
0.64

uskHLT
2.41
0.73
0.51
1.01
1.41
3.68
0.56
0.58
0.28
11.43

±SE
0.18
0.06
0.11
0.11
0.16
0.47
0.06
0.05
0.04
0.74

Mann-Whitney U Test
0.078
0.000
0.311
0.001
0.000
0.001
0.048
0.000
0.000
0.001

Table 3.5 shows amino acid quantification results in fractional values of egkHLT and
usKHLT, standard error values, and results of Mann-Whitney U test (p-values,
bolded numbers are statistically significant).

Other metabolites
Table 3.6 shows the quantified (arbitrary units respective to TSP) values of the
other metabolites looked at in our data set. Metabolites that are higher in egkHLT include
cytosine, glucose, hypoxanthine, and uracil. Metabolites higher in uskHLT are 1methylhistamine, bile acids, choline, ethanol, fumarate, galactose, lactate, malate,
methylamine, pyruvate, succinate, sucrose, taurine, and trimethylamine. Mann-Whitney
U-Test indicated that differences bile acids, choline, ethanol, hypoxanthine, lactate,
malate, methylamine, pyruvate, succinate, sucrose, taurine, and uracil were statistically
significant (p≤0.05).
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Table 3.6: Metabolites quantification results
Metabolite
egkHLT ±SE uskHLT ±SE Mann-Whitney U Test
1-Methylhistamine
0.90 0.10
1.28 0.21
0.122
Bile Acids
0.04 0.00
0.13 0.05
0.006
Choline
0.04 0.01
0.09 0.02
0.001
Cytosine
0.81 0.08
0.58 0.06
0.066
Ethanol
0.60 0.07
1.34 0.34
0.002
Fumarate
0.08 0.01
0.12 0.02
0.364
Galactose
0.09 0.01
0.18 0.12
0.575
Glucose
1.34 0.16
1.02 0.22
0.311
Hypoxanthine
0.56 0.06
0.32 0.04
0.002
Lactate
0.85 0.05
1.30 0.12
0.005
Malate
0.99 0.09
1.59 0.25
0.010
Methylamine
0.18 0.01
0.24 0.02
0.015
Pyruvate
0.09 0.01
0.21 0.03
0.000
Succinate
0.30 0.09
1.27 1.13
0.013
Sucrose
0.42 0.06
0.94 0.17
0.004
Taurine
0.65 0.06
1.49 0.27
0.001
Trimethylamine
0.08 0.01
0.08 0.01
0.790
Uracil
0.75 0.08
0.46 0.05
0.022
Table 3.6 shows metabolite quantification results in fractional values of egkHLT and
usKHLT, standard error values, and results of Mann-Whitney U test (p-values,
bolded numbers are statistically significant).

Figure 3.4 shows the comparison of select metabolites that differed between
groups. All the SCFAs are grouped showing a higher percentage in egkHLT (83%)
compared to uskHLT (75%). All the amino acids are grouped showing a higher
percentage in uskHLT (11%) compared to egkHLT (8%). Bile acids, choline, and taurine
are all grouped because of their involvement with bile acids and are higher in uskHLT
(0.13%, 0.09%, 1.49%) compared to egkHLT (0.04%, 0.04%, 0.7%), respectively.
Galactose, glucose, and sucrose were also grouped because they are all sugars. Galactose
and sucrose are higher in uskHLT (0.18%, 0.94%) compared to egkHLT (0.09%, 0.42%).
Glucose is higher in egkHLT (1.34%) compared to uskHLT (1.02%).
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Figure 3.4: Fractional abundance percentages of metabolites

Figure 3.4 shows fractional abundance percentages of selected metabolite
quantification results, egkHLT (red) and uskHLT (green). Groups include
SCFAs, amino acids, compounds involved with bile acids, and sugars.

Metabolite validation
Figures 3.5-3.11 show uskHLT31 spectrum before any addition of metabolite
solutions and the spectra after the metabolite solutions were added. The spike-ins
confirmed peak assignments that were located in crowded regions of the 1H NMR
egkHLT/uskHLT spectra. Validations were successful and yielded the expected peaks
based on a database search (HMBD).
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Figure 3.5: Galactose validation

Figure 3.5 shows galactose validation through the spike-in procedure. The black line is the
spectrum before the metabolite solution was added and the red line is after.

Figure 3.6: Glucose validation

Figure 3.6 shows glucose validation through the spike-in procedure. The black line is the
spectrum before the metabolite solution was added and the red line is after.
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Figure 3.7: Methylamine validation

Figure 3.7 shows methylamine validation through the spike-in procedure. The black line is
the spectrum before the metabolite solution was added and the red line is after.

Figure 3.8: Sucrose validation

Figure 3.8 shows sucrose validation through the spike-in procedure. The black line is the
spectrum before the metabolite solution was added and the red line is after.
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Figure 3.9: Isoleucine and leucine validation

Figure 3.9 shows isoleucine and leucine validation through the spike-in procedure. The black
line is the spectrum before the metabolite solution was added and the red line is after.

Figure 3.10: Uracil validation

Figure 3.10 shows uracil validation through the spike-in procedure. The black line is the
spectrum before the metabolite solution was added and the red line is after.
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Figure 3.11: Tryptophan validation

Figure 3.11 shows Tryptophan validation through the spike-in procedure. The black line is the
spectrum before the metabolite solution was added and the red line is after. The peak that was
validated is at 7.54 ppm
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Ordination analyses of metabolite data
Principle component analysis
Figure 3.12 shows PCA carried out in MATLAB R2014a. This model
demonstrates that there is enough variability within the measured metabolites levels that
can two distinct clusters that correspond to nationality of groups. The model's p-value (p<
0.001) is statistically significant.
Figure 3.12: PCA plot of metabolite data

p<0.001

Figure 3.12 is the plot of principle components analysis of egkHLT
(red) and uskHLT (green) samples. This data is based on the
quantified metabolite data.
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Orthogonal projection to latent structure discriminate analysis
Figure 3.13 shows the OPLS-DA model with large group separation of T and little
separation of T orthogonal. The model demonstrates that the metabolite variability in
samples is separated into two groups and samples were placed in the correct groups. The
model's p-value (p < 0.001) is statistically significant. The Q2 value was 0.73 meaning the
model had predictive ability.
Figure 3.13: OPLS-DA plot of metabolite data

p<0.001

Figure 3.13 is the plot of orthogonal projection to latent structure
discriminate analysis of egkHLT (red) and uskHLT (green) samples.
This data is based on the quantified metabolite data.
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Random forest
Figure 3.14 shows Random forest ability to classify samples based on variability
in metabolite levels into nationalities. RF also determined metabolites that are important
for separation of the two nationalities. The mean decrease gini is the importance of each
variable in classifying the data. The top 12 important metabolites are shown in Table 3.7,
uracil has the highest score
Figure 3.14: Random forest plot

p<0.001

Figure 3.14 is the plot of random forest of egkHLT (red) and uskHLT
(green) samples. This data is based on quantified metabolite data.
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Table 3.7: Mean decrease gini scores
Mean Decrease
Gini
2.5
2.3
2.0
1.7
1.0
1.0
0.7
0.6
0.6
0.5
0.4
0.4

Metabolites
Uracil
Tryptophan
Cytosine
Hypoxanthine
Propionate
Acetate
Aspartic Acid
Choline
Leucine
Butyrate
Formate
Isoleucine

SparCC
Correlation analysis provided by SparCC demonstrated positive and negative
correlations among metabolites and provided information about correlations between
groups of metabolites. Table 3.8 shows the negative correlations between all metabolites
(≤ -0.3 and p ≤ 0.01). Table 3.9 shows positive correlations between all metabolites (≥
0.3 and p ≤ 0.01). Table 3.10 shows the correlations between SCFAs and based on their
median (0.41) they are positively correlated among each other. Table 3.11 shows the
correlations between the amino acids and based on their median (0.17) they are positively
correlated among each other. Table 3.12 shows the correlations between the amino acids,
tryptophan and glycine, and based on their median (0.18) they are positively correlated.
These two are grouped separately because they are higher in egkHLT. Table 3.13 shows
the correlations between nucleotides (uracil, cytosine) and a nucleotide pre-cursor
(hypoxanthine) and based on their median (0.40) they are positively correlated among
each other. Table 3.14 shows the correlations between metabolites involved in
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carbohydrate metabolites and based on their median (-0.4) they are negatively correlated.
Table 3.15 shows the correlations between sugars and based on their median (0.08) they
are positively correlated. Table 3.16 shows the correlations between other metabolites in
the data set and based on their median (0.01) they are positively correlated. Table 3.17
show the correlations between different groups of metabolites. It shows positive
correlations between glycine/tryptophan and SCFAs (0.08), nucleotides and SCFAs
(0.11), metabolites involved in carbohydrate metabolism and SCFAs (0.01), and
metabolites involved in carbohydrate metabolism and amino acids (0.03). It shows
negative correlations between SCFAs and amino acids (-0.11), glycine/tryptophan and
amino acids (-0.07), nucleotides and amino acids (-0.02), sugars and SCFAs (-0.04),
sugars and amino acids (-0.12), other metabolites and SCFAs (-0.07), and other
metabolites and amino acids (-0.01).
Table 3.8: Negative SparCC correlations
Negative Correlations (≤ -0.3)
Metabolites Correlated SparCC Value
formate → taurine
-0.35
glucose → lactate
-0.36
glycine → lactate
-0.40
glucose → leucine
-0.36
glycine → leucine
-0.35
glucose → valerate
-0.49
glycine → valerate
-0.46
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Table 3.9: Positive SparCC correlations
Positive Correlations ( ≥ 0.3)
Metabolites Correlated
SparCC Value
1-methylhistamine → glycine
0.39
1-methylhistamine → taurine
0.51
acetate → butyrate
0.73
acetate → propionate
0.84
alanine → leucine
0.45
butyrate → propionate
0.71
formate → propionate
0.33
glucose → glycine
0.81
isoleucine → leucine
0.55
lactate → leucine
0.34
lactate → valerate
0.40
lysine → taurine
0.33
propionate → valerate
0.34
uracil → tryptophan
0.57

Table 3.10: SCFAs SparCC correlations
SCFAs Correlation
Metabolites Correlated SparCC Value
acetate → butyrate
0.73
acetate → propionate
0.84
acetate → formate
0.21
acetate → valerate
0.16
butyrate → propionate
0.71
butyrate → formate
0.18
butyrate → valerate
0.34
formate → propionate
0.33
formate → valerate
0.20
propionate → valerate
0.37
Median
0.41
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Table 3.11: Amino acid SparCC correlations
Amino Acid Correlations
Metabolites Correlated
SparCC Value
alanine → aspartic acid
-0.05
alanine → isoleucine
0.41
alanine → leucine
0.45
alanine → lysine
0.38
alanine → tyrosine
0.27
alanine → valine
-0.02
aspartic acid → isoleucine
0.16
aspartic acid → leucine
0.15
aspartic acid → lysine
0.15
aspartic acid → tyrosine
0.10
aspartic acid → valine
0.03
isoleucine → leucine
0.55
isoleucine → lysine
0.21
isoleucine → tyrosine
0.38
isoleucine → valine
0.14
leucine → lysine
0.27
leucine → tyrosine
0.46
leucine → valine
0.17
lysine → tyrosine
0.17
lysine → valine
0.03
tyrosine → valine
0.05
Median
0.17

Table 3.12: Tryptophan and glycine SparCC
Tryptophan and Glycine Correlations
Metabolites Correlated SparCC Value
tryptophan → glycine
0.18
Median
0.18

Table 3.13: Nucleotide SparCC correlations
Nucleotide Correlations
Metabolites Correlated
SparCC Value
cytosine → hypoxanthine
0.40
cytosine → uracil
0.59
hypoxanthine → uracil
0.40
Median
0.40
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Table. 3.14: Carbohydrate metabolism SparCC correlations
Carbohydrate Metabolism
Metabolites Correlated SparCC Value
ethanol → fumarate
0.07
ethanol → lactate
-0.04
ethanol → malate
-0.09
ethanol → pyruvate
0.29
ethanol → succinate
0.03
fumarate → lactate
-0.10
fumarate → malate
-0.07
fumarate → pyruvate
-0.02
fumarate → succinate
-0.10
lactate → malate
-0.21
lactate → pyruvate
0.22
lactate → succinate
-0.25
malate → pyruvate
-0.05
malate → succinate
0.03
pyruvate → succinate
-0.04
Median
-0.04

Table. 3.15: Sugars SparCC correlations
Sugars Correlations
Metabolites Correlated SparCC Value
galactose → glucose
0.24
galactose → sucrose
0.08
glucose → sucrose
-0.04
Median
0.08
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Table. 3.16: Other metabolite SparCC correlations
Other Metabolite Correlations
Metabolites Correlated
SparCC Value
1-methylhistamine → bile acids
0.12
1-methylhistamine → choline
-0.04
1-methylhistamine → methylamine
0.14
1-methylhistamine → taurine
0.51
1-methylhistamine → trimethylamine
-0.05
bile acids → choline
0.03
bile acids → methylamine
0.00
bile acids → taurine
0.06
bile acids → trimethylamine
-0.09
choline → methylamine
-0.04
choline → taurine
-0.01
choline → trimethylamine
0.01
methylamine→ taurine
0.11
methylamine → trimethylamine
-0.02
taurine → trimethylamine
-0.06
Median
0.01

Table 3.17: Correlations between different groups of metabolites
Correlations Between Groups
Metabolites Correlated
Median
SCFAs → amino acids
-0.11
nucleotides → SCFAs
0.11
nucleotides → amino acids
-0.02
glycine/tryptophan → SCFAs
0.08
glycine/tryptophan → amino acids
-0.07
carbohydrate metabolism→ SCFAs
0.01
carbohydrate metabolism → amino acids
0.03
sugars → SCFAs
-0.04
sugars → amino acids
-0.12
other metabolites → SCFAs
-0.07
other metabolites → amino acids
-0.01
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Figure 3.15 demonstrates the correlation network of the metabolite data. SCFAs are
correlated positively among each other and negatively between amino acids. Nucleotides
are correlated positively among each other and positively between SCFAs. Amino acids
are positively correlated among each other, except glycine and tryptophan which are
negatively correlated to the other amino acids. Although a lot of these correlations are
weak it gives us a better understanding as to what metabolites might interact with each
other and their possible influence on each other.
Figure 3.15: SparCC correlation network

Figure 3.15 demonstrates the correlation network based on statistically significant
SparCC values. Red lines are positive correlations and green lines are negative
correlations. Saturation of the line corresponds to the strength of the correlation. The
boxes represent metabolites and their abundance (lighter purple = less abundant, darker
purple = more abundant) within the data set.
*Image was created by V. Shankar
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4. Discussion
This work aimed to determine if there is a difference in metabolite profiles of
fecal material collected from adolescents in two distinct geographical locations. Using 1H
NMR, egkHLT and uskHLT fecal metabolite levels were quantified and compared.
Differences are thought to be an effect of diet differences of the Egyptian population and
US population. These metabolite differences may cause certain health effects on the host.

Sample ordination analyses
Ordination analyses of the binned NMR data showed that the samples formed two
distinct groups and could be classified based on nationality. Ordination analyses of
metabolite data demonstrated that variability within the quantified metabolites formed
two distinct clusters and samples could be classified based on nationality. Quantified
metabolite data analyses also showed that uracil was the most important metabolite for
classifying the data. Correlation analysis by SparCC showed positive and negative
correlations within the metabolite data set. It also showed inter and intra correlations
among the following groups: SCFAs, amino acids, tryptophan and glycine, carbohydrate
metabolism metabolites, sugars, and the other metabolites in the data set.

Differences in Metabolite Levels Between egkHLT and uskHLT
The data shows that levels of SCFAs are higher in egkHLT compared to uskHLT.
This may be due to the high intake of dietary fiber in the Egyptian diet. Egyptians have
been shown to intake around 31g per day of fiber [61]. Dietary fiber is found in foods
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such as whole grains, legumes, fruits, and vegetables [62]. The Egyptian’s diet main food
staples are bread made from high extraction wheat flour, cereals, legumes, and fresh dark
leafy green vegetables [47]. The dietary fiber acquired from these foods can be converted
into SCFAs in the colon by bacteria. In the United States, the recommended amount of
dietary fiber is around 25g per day for women and 38g per day for men. However,
Americans are only consuming around 15g per day [62]. This difference in dietary fiber
intake could be a major contributor to the difference between the egkHLT/uskHLT fecal
metabolite levels. SCFAs have been shown to have important anti-inflammatory effects
which could potentially be used as therapies for gastrointestinal inflammatory diseases
such as IBD [24].
The levels of almost all amino acid levels were higher in the uskHLT samples.
This may also be linked to diet differences and the high amount of protein found in foods
such as meats. According to an article about trends in meat consumption in the United
States, children ages 12-19 consumed 121.8g per day of meat products [29]. Meat in take
in Egypt is only around 72g per day [61]. Meat consumptions may be lower because it is
a luxury item and religious and cultural observations prevent some Egyptians from eating
meat at certain times [47]. This high meat consumption in the United States could play a
key role in the development of several health diseases such as colorectal cancer [28].
Another difference shown in our data is that the amino acid tryptophan is higher
in egkHLT compared to uskHLT. Tryptophan is high in foods such as seeds, legumes,
soy protein, dairy products, and animal protein [63]. In a study done by Young et. al.,
they showed that tryptophan is slightly higher in plant protein sources (nuts, seeds, and
legumes) than in animal protein [64]. In the US only around 30% of protein intake comes
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from plants where as almost 70% comes from animal protein. However, in Africa and
Middle East around 14% of protein intake is animal and around 79% is plant [64]. This
could account for the levels of tryptophan being higher in egkHLT.
Other metabolites also show a difference between egkHLT and uskHLT. For
example, bile acids are higher in uskHLT. Bile acids are increased during high fat intake
and high fat foods seem to be consumed more in the US diet [32]. The Dietary Guidelines
for American’s say that adolescents should only consume 30% of calories from fat and
only 10% of that fat from saturated fats [65]. A study by Reedy et. al., determined based
on National Health and Nutrition Examination Survey (NHANES) showed that 40% of
total energy (798 of the 2,027 kcal per day) consumed by 2-18 year olds, came from solid
fat and added sugars. The major sources of these fats were from pizza, grain desserts,
whole milk, cheese, and fatty meats [66]. Egyptian diet tends to be lower in saturated fats
[47]. In a study done by Galal, dietary energy from fat in Egypt was 28.7% for children,
and primarily came from vegetable oil in mixed dishes [67]. This is almost 10% lower
than US adolescents and could account for the difference in levels of bile acids. Increased
bile acid levels have been linked to a variety of cancers in humans [32].
Another metabolite found higher in uskHLT samples was taurine. Taurine is
present in many foods and is high in foods such as meat, fish, and energy drinks. Meat
and fish can contain anywhere from 300-6000 mol per 100g per wet weight of taurine.
As where fruits, vegetables, nuts, and legumes contain ranges less than 1 mol per 100g
per wet weight [36]. Meat consumption as mentioned above seems to be more prevalent
in the United States diet. Another source of taurine in the United States diet is through
energy drinks. Energy drinks are a billion dollar business in the United States and half of
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the market is consumed by adolescents (< 12, 12-18 years old) and young adults (19-25
years old) [37]. Energy drinks which usually come in 16 or 24 oz cans, can contain up to
1,000 mg of taurine in an 8.0-8.4 ounce serving [68]. According to one article, thirty-one
percent of energy drink consumers are ages 12-17 years old and 28 percent of 12-14 year
olds report to regularly consume energy drinks, which is the average age of the uskHLT
cohort [69]. The high consumption of meat and energy drinks could account for the
higher amount of taurine in the uskHLT samples. Over consumption of taurine can cause
adverse effects such as increased heart rate and hypoglycemia [37].
Choline was also found to be higher in uskHLT. Choline is rich in foods such as
eggs, liver, and peanuts. In the US diet the major contributors of choline includes meat,
poultry, egg-based dishes, and dairy foods [70]. Choline can also be found in wheat and
spinach, which are main staples in the Egyptian diet [70]. However, high meat intake as
mentioned before in the US diet could be the reason for the slight increase choline levels
in uskHLT. Choline deficiency has been linked to liver and muscle dysfunction [39].

Connections to previous studies
Previous studies have shown a link in diet and metabolite differences among
different groups of people. However, most of these studies focus on specific groups of
metabolites and use techniques other than NMR for metabolite quantification. For
example, as mentioned in the introduction an article by De Flippo et. al. compared levels
of SCFAs between an African group of adolescents from Burkina Faso (BF) and
European adolescents from Florence, Italy (EU) [45]. The researchers believed that diet
differences caused changes in the microbiota composition and this resulted in the higher
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amount of SCFAs in the BF cohort. The SCFAs quantifications were determined by mass
spectrometry [45]. Another study compared individuals on two different short-term diets,
one consisting of plant-based foods and one of animal product based foods. Using gas
chromatography and mass spectrometry they determined that people on the animal-based
diet had higher levels of bile acids (specifically DCA) and people on the plant-based diet
had higher levels of SCFAs [71]. These examples prove that diet differences can be
linked to differences in metabolites and we wanted to expand on that concept by looking
at more metabolites using the nondestructive and noninvasive technique of NMR.

Conclusion
1

H NMR analysis on fecal material has been previously shown by researchers as a

valuable tool to determine metabolite profiles [39, 40]. This study confirms this approach
and concludes that there are differences in metabolite profiles between Egyptian and US
adolescents. Major differences include, SCFAs being higher in egkHLT samples and
most amino acids being higher in uskHLT samples. These differences in metabolite
levels is thought to be due to the varying diets of the two populations. Based on a
literature, I was able to link certain metabolites to dietary products and determine their
involvement with human health. Although my analysis is limited to fecal material and 32
metabolites, my hope is that other researchers can use the same concepts and methods to
look at other parameters (blood, urine) and gain a more comprehensive profile of
metabolites between individuals. I also hope this work can help scientist and medical
professionals gain a better knowledge as to what foods influence metabolite profiles and
how this could promote or be detrimental to human health.
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